Common Contracts
1 similar Agreement and Plan of Merger contracts
Acquisition agreement for Iveric BioAgreement and Plan of Merger • November 14th, 2024 • Delaware
Astellas Pharma and Iveric bio announced that on April 29, 2023 the Companies have entered into a definitive agreement under which Astellas through Berry Merger Sub, a wholly-owned subsidiary of Astellas US Holding, has agreed to acquire 100% of the outstanding shares of Iveric Bio for US$40.00 per share in cash for a total equity value of approximately US$5.9 billion.
